Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study ; volume:16 ; number:1 ; day:25 ; month:7 ; year:2016 ; pages:1-9 ; date:12.2016
BMC cancer ; 16, Heft 1 (25.7.2016), 1-9, 12.2016
- Urheber
-
del Puerto-Nevado, Laura
- Beteiligte Personen und Organisationen
-
Marin-Arango, Juan Pablo
Fernandez-Aceñero, Maria Jesus
Arroyo-Manzano, David
Martinez-Useros, Javier
Borrero-Palacios, Aurea
Rodriguez-Remirez, Maria
Cebrian, Arancha
Gomez del Pulgar, Teresa
Cruz-Ramos, Marlid
Carames, Cristina
Lopez-Botet, Begoña
Garcia-Foncillas, Jesus
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2574-9
- URN
-
urn:nbn:de:1111-201607275221
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- del Puerto-Nevado, Laura
- Marin-Arango, Juan Pablo
- Fernandez-Aceñero, Maria Jesus
- Arroyo-Manzano, David
- Martinez-Useros, Javier
- Borrero-Palacios, Aurea
- Rodriguez-Remirez, Maria
- Cebrian, Arancha
- Gomez del Pulgar, Teresa
- Cruz-Ramos, Marlid
- Carames, Cristina
- Lopez-Botet, Begoña
- Garcia-Foncillas, Jesus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study
Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials
Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer
What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer
Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation
Short–term effects of neoadjuvant chemoradiation therapy on anorectal function in rectal cancer patients: a pilot study
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study
Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials
Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer
What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer
Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation
Short–term effects of neoadjuvant chemoradiation therapy on anorectal function in rectal cancer patients: a pilot study
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study
Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials
Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer
What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer
Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation